# Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection

> **NCT06461351** · — · RECRUITING · sponsor: **Juventas Cell Therapy Ltd.** · enrollment: 1000 (estimated)

## Conditions studied

- B-cell Tumors

## Interventions

- **OTHER:** Inaticabtagene autoleucel Injection

## Key facts

- **NCT ID:** NCT06461351
- **Lead sponsor:** Juventas Cell Therapy Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-30
- **Primary completion:** 2039-05-30
- **Final completion:** 2040-03-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461351, "Long-term Observational Study of Patients Treated With Inaticabtagene Autoleucel Injection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06461351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*